Table 2.
Accuracy of ERUS for each T stage without neoadjuvant therapy, throughout the whole study period (n = 67).
| uT1 | uT2 | uT3 | |
|---|---|---|---|
| uT-pT correspondence (kappa coefficient) | 0.465 | 0.411 | 0.606 |
| Sensitivity | 75% | 73% | 58% |
| Specificity | 74% | 80% | 96% |
| PPV | 85% | 42% | 78% |
| NPV | 61% | 94% | 91% |